Compare Proposed Merger Remedies Against Precedent Commitment Decisions

Skill: Merger Remedies Deviation Assessment

1. Subject-matter triage

• Confirm the analysis scope is a remedies comparison, not a merits memo on the merger itself.
• Identify the three precedent commitment decisions, the proposed remedies package, the SO summary, and the market data as the governing source set.
• Enumerate the remedy components that are actually in scope before comparing them; if only one component is present, state that expressly.
• Separate structural commitments, behavioral commitments, monitoring mechanics, purchaser criteria, employee transfers, licensing, supply, and escalation provisions into distinct analytical lanes.

2. Failure modes the skill is correcting

• Remedy gaps are described in the abstract without tying them to what the precedent decisions required, allowed, limited, or rejected.
• Economic terms are compared loosely rather than against the actual commercial structure reflected in the precedent materials.
• Structural and behavioral remedies are treated as interchangeable, without accounting for the stronger scrutiny often applied to behavioral commitments in concentrated or technically complex markets.
• The analysis notes a deviation but stops short of quantifying its scale from the record, linking it to interacting provisions, and explaining the downstream consequence.
• The memo identifies problems without ranking severity or giving a usable recommendation path.
• The memo states a conclusion about adequacy or risk without naming the antitrust remedy principle, commitment standard, or institutional practice supporting it.

3. Legal frameworks / domain conventions that apply

• Compare the proposal against the commitment standards reflected in the precedent decisions, including the level of specificity, duration, enforceability, and monitoring expected for an effective remedy package.
• Apply the structural-remedy-first convention: assess whether divestiture or other structural relief can preserve competition before relying on behavioral obligations.
• Test whether any proposed behavioral commitment is sufficiently durable, self-executing, and administrable for the market at issue.
• For divestiture concepts, assess standalone viability, buyer suitability, timing risk, and whether the package preserves competitive independence after closing.
• For supply commitments, assess whether the term is long enough for transition to independence in light of product complexity and switching friction.
• For licensing commitments, assess scope, field, exclusivity, sublicensing limits, know-how access, and whether compensation or other commercial terms preserve competitive independence.
• For employee-transfer commitments, assess whether the transferred personnel categories support continuity of the relevant business functions.
• For purchaser criteria, assess whether the screening standard covers operational capability, financial strength, and any market-specific technical or regulatory requirements.
• For monitoring trustees, assess appointment mechanics, mandate, escalation authority, reporting lines, and the adequacy of the monitoring period.
• Where a legal proposition is stated, identify the controlling authority or precedent basis by name, article, section, regulation, or other governing citation as reflected in the source materials or standard competition-remedy practice.

4. Analytical scaffolds

1. Build a component-by-component comparison matrix: for each remedy element, capture the precedent standard, the proposed term, the deviation, the practical risk, and the recommended fix.
2. For each issue, close the analysis in three steps: measure the issue against a figure, term, threshold, or other metric in the record; cross-reference the clause, schedule, or document that interacts with it; then state the operational, regulatory, or transactional consequence.
3. Evaluate each remedy component against the remedy hierarchy first, then against enforceability and administrability.
4. For divestiture-related provisions, test standalone viability, purchaser fit, and any timing backstop or escalation mechanism.
5. For supply and licensing provisions, compare duration, scope, commercial terms, and transition support against the precedent decisions and explain whether the terms risk preserving dependence.
6. For monitoring provisions, test whether the trustee role is defined closely enough to detect non-compliance and force timely reporting.
7. For purchaser and employee-transfer terms, assess whether the package supports a credible handoff of the business as a going concern.
8. If the source set contains multiple remedy components or multiple precedent commitments, analyze each item separately; do not collapse them into a single generalized pass.
9. If a component is absent from the proposal but present in precedent, flag the omission as a deviation and assess whether the gap is material or merely formal.
10. When the market data bear on risk, use them to explain why the deviation matters in practice, not just that it exists.

5. Vertical / structural / temporal relationships

• Note whether one remedy element depends on another, such as a license that only works if personnel, data access, or supply continuity is also secured.
• Track escalation timing, transition periods, reporting cadence, and any deadline-sensitive backstop provisions.
• Assess whether a behavioral obligation is temporary bridge relief or whether it functions as the core remedy; if the latter, explain the heightened risk.
• If a monitoring or trustee mechanism extends across phases, identify what changes at each stage and whether oversight remains effective throughout.
• If the package combines structural and behavioral elements, explain how the pieces interact and whether any weaker term undermines the stronger one.

6. Output structure conventions

• Use a memo format with a short executive summary, a comparison matrix, an issue register, and a recommendations section.
• Define an ordinal severity scale once near the start and apply it consistently to every issue.
• Each issue entry should follow a fixed sequence: precedent standard → proposed term → deviation → severity/risk → consequence → recommendation.
• Include the applicable source basis for each issue, using the governing precedent, rule, or practice authority named in the source materials where available.
• For each issue, state the interaction with at least one related term or document and the consequence for competition, execution, or enforceability.
• End with an explicit Recommended Actions section that lists concrete next steps in imperative form, assigns the responsible role, and ties each action to a transactional or regulatory timing anchor.
• Keep recommendations implementation-focused: identify what should be revised, clarified, added, or removed before submission.
• Use industry-conventional memo headings rather than a rubric-like checklist.